Elevated levels of TGFα in premalignant, dysplastic, and HNSCC patients suggests that upregulation of TGFα represents an early event in HNSCC pathogenesis [74,76,77]. This evidence concerns the gene TGFA and head and neck squamous cell carcinoma.